GGrantIndex
Sort

326,823 grants matching clinical trial

M. D. Anderson Cancer Center SPORE in Multiple Myeloma

$2,161,999
Robert Zygmunt Orlowski · University Of Tx Md Anderson Can Ctr · P50 · FY2014 · CA

SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia

$2,161,999
Hagop Kantarjian · University Of Tx Md Anderson Can Ctr · P50 · FY2016 · CA

SARC Sarcoma SPORE

$2,161,999
Laurence H Baker · Sarc · U54 · FY2016 · CA

Yale SPORE in Skin Cancer

$2,161,999
Ruth Halaban · Yale University · P50 · FY2016 · CA

SPORE in Prostate Cancer

$2,161,999
Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2016 · CA

SPORE in Breast Cancer

$2,161,998
Carlos L Arteaga · Vanderbilt University · P50 · FY2014 · CA

Translational Research in Breast Cancer (SPORE)

$2,161,998
C Kent Osborne · Baylor College Of Medicine · P50 · FY2016 · CA

Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer

$2,161,996
Roy S Herbst · Yale University · P50 · FY2016 · CA

SPORE: Brain Tumore SPORE Grant

$2,161,996
Mitchel S. Berger · University Of California, San Francisco · P50 · FY2014 · CA

SPORE in Skin Cancer

$2,161,838
John Munn Kirkwood · University Of Pittsburgh At Pittsburgh · P50 · FY2014 · CA

Targeted antigen receptor treatment of cancer

$2,161,758
David A Scheinberg · Sloan-Kettering Inst Can Research · P01 · FY2008 · CA

Immunologic control of HIV-1 through combination bNAbs and biologics.

$2,161,658
Marina Caskey · Rockefeller University · U01 · FY2020 · AI

Phase lll Study of the Effects of Selenium on Ademonas

$2,161,546
M. Peter Lance · University Of Arizona · P01 · FY2008 · CA

Administrative Core

$2,161,448
Hagop Kantarjian · University Of Tx Md Anderson Can Ctr · P50 · FY2014 · CA

SPORE University of Texas M.D. Anderson Cancer Center SPORE-Leukemia

$2,161,448
Hagop Kantarjian · University Of Tx Md Anderson Can Ctr · P50 · FY2014 · CA

Specialized Programs of Research Excellence (SPORE) in Human Cancer

$2,161,375
George J Weiner · University Of Iowa · P50 · FY2016 · CA

NCI ET-CTN with Phase i Emphasis at UPCI

$2,161,338
Edward Chu · University Of Pittsburgh At Pittsburgh · UM1 · FY2018 · CA

SPORE: Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer

$2,161,168
Eric P Winer · Dana-Farber Cancer Inst · P50 · FY2016 · CA

NORTHWESTERN ADULT AIDS CLINICAL TRIALS UNIT

$2,161,146
Northwestern University · U01 · FY2002 · AI

Autism Adaptive Community-based Treatment to Improve Outcomes using Navigators (ACTION) Network

$2,160,993
Amy M Wetherby · Florida State University · R01 · FY2017 · HD

A Neuromusculoskeletal Interface for Bionic Arms: A Randomized Crossover Study

$2,160,832
Levi John Hargrove · Rehabilitation Institute Of Chicago D/B/A Shirley Ryan Abilitylab · UH3 · FY2025 · NS

Gene Therapy for Leber Congenital Amaurosis

$2,160,789
University Of Florida · U10 · FY2001 · EY

Clinical Vector for TCR Immunotherapy Targeted to Melanoma

$2,160,774
Boro Dropulic · Lentigen Corporation · R44 · FY2011 · CA

Translational Hearing Center

$2,160,551
Peter S Steyger · Creighton University · P20 · FY2025 · GM

CENTRAL DATA COLLECTION CENTER (CDCC) CONTINUED FOLLOW-UP OF PLCO

$2,160,252
Sunitha Mathew · Westat, Inc. · N01 · FY2014 · CA